This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Deloitte Consulting LLP as the prime contractor. The BPA has a ceiling value of $500,000,000 and a period of performance from August 26, 2024, to August 26, 2029.
The BPA was established under the Multiple Award Schedule (MAS) program to provide the FDA with a range of services for modernizing their data and analytics capabilities. This includes IT modernization, data analytics, cybersecurity, program management, and organizational transformation support. Deloitte often partners with small businesses and specialized firms as subcontractors to deliver these services. The BPA allows Deloitte to compete for task orders across the FDA and potentially other agencies, leveraging its extensive experience supporting the Department of Health and Human Services and other federal civilian and defense agencies.
Generated 8/27/24, 9:09 AM